For employer plans, a single member using GLP-1 therapy can add thousands of dollars per year to claims costs
Less gastrointestinal discomfort Less Gastrointestinal Discomfort - Sourced: Vecteezy Compared with the oral version, the injectable semaglutide is usually less likely to cause gastrointestinal discomfort (such as nausea, vomiting, etc.) due to bypassing the gastrointestinal tract, allowing some patients to tolerate it better
Finally, we also suggest that clients concurrently stack N-acetylcysteine (NAC) supplementation when working to increase their glutathione (GSH) and overall antioxidant levels
Using ImageJ (Fiji, version 1.48), a computerized image analysis was taken
After 72 weeks of treatment, participants on the highest dose (15 mg weekly) lost an average of 22.5% of their body weight